Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review.

Enrique GrandeÁngel DíazCarlos LópezJavier MunarrizJuan-José ReinaRuth VeraBeatriz BernárdezJavier AllerJaume CapdevilaRocio Garcia-CarboneroPaula Jimenez FonsecaMarta Trapero-Bertran

Published in: Therapeutic advances in endocrinology and metabolism (2019)

There is a lack of data related to resource utilization in the field of GEP-NETs. Therefore, cost-effectiveness and budget impact studies of existing and emerging treatments are urgently needed to help the decision-making process for patients with NETs.

Keyphrases

neuroendocrine tumors
decision making
electronic health record
big data
case control
machine learning
artificial intelligence
deep learning
drug induced